Investing in Infrastructure: Here’s why it is lucrative and how investors should go about it
Investing in infrastructure can be a lucrative and beneficial decision for both individuals and governments. Infrastructure refers to the basic physical…
Ozempic: Here’s why 2023’s star obesity treatment is causing headaches for CSL and several other biotech stocks
Ozempic is one of the few things giving CSL (ASX:CSL) shareholders sleepless nights right now. And you could argue this…
The ASX & SGX: Imagine if the proposed $8.4bn merger had actually gone ahead
Remember when the Singapore Exchange (SGX) made a A$8.4bn bid for the ASX? It was over a decade now, but we…
Rejecting a takeover offer: Here are 5 ASX stocks that did and how it ended for them
Rejecting a takeover offer is a bold step for an ASX company to take. It is turning down sweet quick…
Why has the Aussie dollar been weak in 2023 and is this good or bad for shares?
Just over a decade ago, the Aussie dollar was on parity with the US dollar, meaning you could buy a…
‘Don’t Catch a Falling Knife’: Here’s what this saying means and 3 ways to avoid it
Don’t Catch a Falling Knife: Have you ever heard that phase? If you haven’t, this article is for you because…
Why Telstra’s $267.5m purchase of Versant is a very big deal for investors
Earlier this week, Telstra (ASX:TLS) forked out $267.5m to buy cloud computing Versant. Given Telstra’s $40bn+ market cap, this may…
Why did uranium prices drop for over 10 years post-GFC? And are thing back on track now?
Why did uranium prices drop for the best part of a decade and a half until now? It was a…
After hours trading: Here’s how it works on the ASX & internationally
The ASX may be ‘officially’ open for only 6 hours a day, but after hours trading extends it significantly. In this…
Nearology: A trap ASX resources and mining stock investors commonly fall for
Nearology is one of the most common traps that ASX resources and mining stock investors fall for. This refers to the…
What is the Rule of 40 and why do SaaS stocks use it as a critical yardstick?
In this article, we look at The Rule of 40, which is a principle that is highly regarded in the world…
FDA approval: Here’s how ASX biotechs and medtechs obtain it
Last week one of our favourite companies Cyclopharm (ASX:CYC) obtained FDA approval, a goal it had been striving for years…
5 of the most important investor conferences you need to know about
In this article, we recap the 5 most important investor conferences that ASX investors should know about. The ones we…